Artificial Intelligence in Diagnostics Market

The Artificial Intelligence in Diagnostics Market size was valued at USD 7.63 Billion in 2023 and the total Artificial Intelligence in Diagnostics revenue is expected to grow at a CAGR of 45% from 2024 to 2030, reaching nearly USD 102.84 Billion.

Artificial Intelligence in Diagnostics Market Overview

Artificial intelligence (AI) is the process of creating unique systems using processes and software that can complete tasks without the need for human interaction. Artificial intelligence technologies include machine learning, natural language processing, reasoning, and insight. It's used in medicine to replicate human perception and draw conclusions from complicated medical and diagnostic data given in graphs or other visuals. In healthcare, artificial intelligence is largely employed to investigate the link between treatment approaches and patient results. Diagnostic processes, medication research, customized medicines, and patient monitoring care are all areas where AI systems are being used.

The report has covered the market trends from 2015 to forecast the market through 2030. 2023 is considered a base year however 2023’s numbers are on the real output of the companies in the market. Special attention is given to 2021 and the effect of lockdown on the demand and supply, and also the impact of lockdown for the next two years on the market. Some companies have done well in lockdown also and specific strategic analysis of those companies is done in the report.To know about the Research Methodology :- Request Free Sample Report

Artificial Intelligence in Diagnostics Market Dynamics

Artificial intelligence (AI) is expected to gain traction in diagnostics because of increased investments from nonprofits and private corporations to improve information interchange and clinical results as well as cost savings. Also, higher government spending on healthcare is supporting market growth by increasing demand for e-diagnostic services in the healthcare sector. In addition, the rising need for low-cost diagnostic procedures, effective and efficient report analysis and rapid diagnostic data creation are just a few of the reasons expected to propel the market's growth during the forecast period.

Similarly, startups creating AI-driven imaging and diagnostic solutions are the other major drivers of market growth. The business uses Artificial Intelligence and Machine Learning to aid in the prevention, detection, and diagnosis of acute and chronic cardiac problems. China, the United States, and the United Kingdom are becoming attractive centers for healthcare innovation. Healthcare AI startups in China have profited from the government's AI-focused growth plan, which has encouraged investment and public-private partnerships. For example, the five-year-old business has aided 3 million patients internationally using Artificial Intelligence and Machine Learning.

Restraints: These Artificial intelligence-based technologies require expertise and experience to work. Healthcare professionals are likewise wary about AI diagnosis' accuracy. This factor is expected to hamper the market growth during the forecast period.

COVID-19 Impact on the Artificial Intelligence in Diagnostics Market

The global artificial intelligence diagnostic market has benefited from the COVID-19-induced pandemic. The usage of AI diagnostic tools for identifying the presence of viruses in the human body increased during the COVID-19 epidemic. Because AI-based solutions and technologies can function rapidly, this has resulted in faster adoption of AI in medical diagnostics.

AI-based tools and solutions for medical image analyses can improve computed tomography in the diagnosis of covid-19 as well as assess the severity of the disease in patients by quantifying lung involvement using deep learning models for automated classification and detection of covid-19 on CT scans. Furthermore, most firms are working on X-ray and CT AI-powered solutions for healthcare systems for patient triage and management. As a result of the emergence of covid-19, the global artificial intelligence in the diagnostics market is growing.

Artificial Intelligence in Diagnostics Market Segmentation Analysis

By Component, in 2023, the software segment dominated the market, accounting for 44.3 percent of total sales. The growing need for cloud-based and AI-powered or upgraded diagnostic solutions to improve diagnostic precision while processing and interpreting medical pictures of patients is driving the segment's growth. Many AI businesses are creating a wide range of software solutions for a wide range of healthcare applications. This is also a significant element driving the growth of the software segment.

Artificial Intelligence in Diagnostics Market Regional Insights

The North American artificial intelligence diagnostic market held a 57 percent revenue share in 2023. This region's market is expected to grow due to a high acceptance rate of AI in healthcare by both public and private companies, as well as substantial government financing for the healthcare sector. Additionally, the United States is the fastest-growing market in North America. For example, there is a considerable increase in the adoption and development of technology-advanced diagnosis software for medical applications in the U.S.

Asia Pacific is expected to emerge as the fastest-growing region during the forecast period. The growing number of government initiatives to encourage healthcare suppliers, as well as cumulative funds from nonprofit organizations and private corporations, better clinical outcomes, and cost savings are expected to drive up demand for AI in diagnostics.

Artificial Intelligence in Diagnostics Market Scope: Inquire before buying

Artificial Intelligence in Diagnostics Market by Region

North America (United States, Canada and Mexico)
Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe)
Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC)
Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A)
South America (Brazil, Argentina Rest of South America)

Artificial Intelligence in Diagnostics Market: Key Players

1. Aidoc
2. GE Healthcare
3. Vuno Inc.
4. Siemens Healthcare GmbH
5. AliveCor
6. Imagen Technologies
7. IDx Technologies Inc.
8. Neural Analytics
9. Riverain Technologies
10. Zebra Medical Vision
11. Siemens AG
12. NovaSignal Corporation
13. Icometrix
14. Koninklijke Philips N.V
15. Caption Health, Inc.

Frequently Asked Questions

1. What was the Global Artificial Intelligence in Diagnostics Market size in 2023?
Ans- The Global Artificial Intelligence in Diagnostics Market size was USD 7.63 Billion in 2023.

2. What are the key driving factors for the growth of Global Artificial Intelligence in Diagnostics Market?
Ans- Artificial intelligence (AI) is expected to gain traction in diagnostics because of increased investments from nonprofits and private corporations to improve information interchange and clinical results as well as cost savings.

3. Which region accounted for the largest Global Artificial Intelligence in Diagnostics Market share?
Ans- The North American artificial intelligence diagnostic market held a 56 percent revenue share in 2023.

4. What makes Asia Pacific a Lucrative Market for Global Artificial Intelligence in Diagnostics Market?
Ans- A growing number of government initiatives to encourage healthcare suppliers, as well as cumulative funds from nonprofit organizations and private corporations, better clinical outcomes, and cost savings, are expected to drive up demand for AI in diagnostics.

5. What are the top players operating in Global Artificial Intelligence in Diagnostics Market?
Ans- Aidoc, AliveCor, GE Healthcare, Imagen Technologies, Vuno Inc., IDx Technologies Inc., Siemens Healthcare GmbH, and Neural Analytics.